Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 1

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Is the treatment of glaucoma limited to topical drops only?

100%
Dyda M., Kręcicka M., Drewniowska J., Góral M., Cugier O., Zając-Pytrus H.
European Journal of Translational and Clinical Medicine
|
2024
|
vol. 7
|
issue 2
111-121
EN
Glaucoma is a degenerative condition characterized by progressive loss of retinal ganglion cells, leading to irreversible vision loss. This review aims to summarize the current knowledge about treatment strategies that optimize and improve glaucoma patients' outcomes. We explored various therapeutic options for glaucoma, highlighting the importance of methods beyond the traditional topical eye drops. We discussed the pharmacological options, as well as the more individualized treatment approaches e.g. surgical interventions and laser therapy. Moreover, we described the role of neuroprotection (e.g. antioxidants, anti-inflammatory agents, NMDAR inhibitors). Further research is needed to confirm the efficacy and safety of these neuroprotective agents. Regarding neovascular glaucoma, we focused on anti-VEGF agents and panretinal photocoagulation. Finally, we analyzed the potential adjunctive role of statins in the treatment of glaucoma. Although there is conflicting evidence regarding the efficacy of statins as a potential adjunctive glaucoma treatment, recent studies suggest possible benefits of this therapy.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.